A new nasal spray known as zavegepant is awaiting approval from federal regulators for acute treatment of migraine. The drug has performed well in clinical...
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health.